ImmunityBio, Inc.IBRXNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank92
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

Latest
$8.57M
↑ 492% vs avg
Percentile
P92
Near historical high
Streak
1 yr
Consecutive growthStrong
Average
$1.45M
Historical baseline
PeriodValueYoY Change
TTM$8.57M-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-
2020$0.00-100.0%
2019$9.01M+389.8%
2018$-3.11M-
2017$0.00-
2016$0.00-